Conference - San Francisco, California, U.S.A.
As the biopharma industry faces the challenge of increasing cost of drug development, increasing emphasis is placed on strategies to accelerate clinical development, reduce late-stage attrition and pursue innovation through collaboration. Cambridge Healthtech Institute's Ninth Annual Clinical and Translational Science conference at the 2013 Molecular Med Tri-Con will bring together thought leaders from academia, industry and government to share strategies to accelerate and de-risk clinical development through better and earlier safety and POC models, the use of translational biomarkers and imaging, novel clinical trial design and patient selection, and collaboration.
(Courtesy of Moscone Center, via en.wikipedia.org)
Wednesday, February 13, 2013 to Friday, February 15, 2013
Moscone North Convention Center, San Francisco, California, U.S.A.
Contact: chi@healthtech.com
Phone: 781-972-5400
Fax: 781-972-5425
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
